Werth VP - Search Results

1

Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study.

Werth VP, Fleischmann R, Robern M, Touma Z, Tiamiyu I, Gurtovaya O, Pechonkina A, Mozaffarian A, Downie B, Matzkies F, Wallace D. Werth VP, et al. Rheumatology (Oxford). 2022 May 30;61(6):2413-2423. doi: 10.1093/rheumatology/keab685. Rheumatology (Oxford). 2022. PMID: 34498056 Free PMC article. Clinical Trial.

2

Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus.

Werth VP, Dutz JP, Sontheimer RD. Werth VP, et al. Curr Opin Rheumatol. 1997 Sep;9(5):400-9. doi: 10.1097/00002281-199709000-00005. Curr Opin Rheumatol. 1997. PMID: 9309195 Review.

3

Current treatment of cutaneous lupus erythematosus.

Werth V. Werth V. Dermatol Online J. 2001 Feb;7(1):2. Dermatol Online J. 2001. PMID: 11328623 Free article. Review.

4

Thalidomide in cutaneous lupus erythematosus.

Pelle MT, Werth VP. Pelle MT, et al. Among authors: werth vp. Am J Clin Dermatol. 2003;4(6):379-87. doi: 10.2165/00128071-200304060-00002. Am J Clin Dermatol. 2003. PMID: 12762830 Review.

5

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. Albrecht J, et al. Among authors: werth vp. J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x. J Invest Dermatol. 2005. PMID: 16297185 Free PMC article.

6

The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.

Bonilla-Martinez ZL, Albrecht J, Troxel AB, Taylor L, Okawa J, Dulay S, Werth VP. Bonilla-Martinez ZL, et al. Among authors: werth vp. Arch Dermatol. 2008 Feb;144(2):173-80. doi: 10.1001/archderm.144.2.173. Arch Dermatol. 2008. PMID: 18283174 Free PMC article.

7

The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology.

Krathen MS, Dunham J, Gaines E, Junkins-Hopkins J, Kim E, Kolasinski SL, Kovarik C, Kwan-Morley J, Okawa J, Propert K, Rogers N, Rose M, Thomas P, Troxel AB, Van Voorhees A, Feldt JV, Weber AL, Werth VP. Krathen MS, et al. Among authors: werth vp. Arthritis Rheum. 2008 Mar 15;59(3):338-44. doi: 10.1002/art.23319. Arthritis Rheum. 2008. PMID: 18311759 Free PMC article.

8

Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Moghadam-Kia S, Chilek K, Gaines E, Costner M, Rose ME, Okawa J, Werth VP. Moghadam-Kia S, et al. Among authors: werth vp. Arch Dermatol. 2009 Mar;145(3):255-60. doi: 10.1001/archdermatol.2008.594. Arch Dermatol. 2009. PMID: 19289753 Free PMC article.

9

Lenalidomide for the treatment of resistant discoid lupus erythematosus.

Shah A, Albrecht J, Bonilla-Martinez Z, Okawa J, Rose M, Rosenbach M, Werth VP. Shah A, et al. Among authors: werth vp. Arch Dermatol. 2009 Mar;145(3):303-6. doi: 10.1001/archdermatol.2009.30. Arch Dermatol. 2009. PMID: 19289762 Free PMC article.

10

Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Klein RS, Morganroth PA, Werth VP. Klein RS, et al. Among authors: werth vp. Rheum Dis Clin North Am. 2010 Feb;36(1):33-51, vii. doi: 10.1016/j.rdc.2009.12.001. Rheum Dis Clin North Am. 2010. PMID: 20202590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

463 results

Search Page

Filters